International variations in bladder cancer incidence and mortality
- PMID: 24451595
- DOI: 10.1016/j.eururo.2013.10.001
International variations in bladder cancer incidence and mortality
Abstract
Context: Previous studies have reported substantial worldwide regional variations in bladder cancer (BCa) incidence and mortality.
Objective: To describe contemporary international variations in BCa incidence and mortality rates and trends using the most recent data from the International Agency for Research on Cancer (IARC).
Evidence acquisition: Estimated 2008 BCa incidence and mortality rates for each country by sex were obtained from GLOBOCAN. Recent trends in incidence for 43 countries and in mortality for 64 countries were assessed by join-point model using data from the IARC's Cancer Incidence in Five Continents and from the World Health Organisation's mortality database, respectively.
Evidence synthesis: The highest incidence rates for both men and women are found in Europe, the United States, and Egypt, and the lowest rates are found in sub-Saharan Africa, Asia, and South America. Mortality rates are highest in parts of Europe and northern Africa and lowest in Asia, Central America, and middle Africa. Incidence rates among men decreased in 11 of 43 countries (46 registries) (North America, western and northern Europe), remained stable in 20, and increased in 12 countries (southern, central, and eastern Europe). Among women, incidence rates decreased in 10 countries, stabilised in 22 countries, and increased in 12 countries. Mortality rates among men decreased in 32 of 65 countries (throughout all world regions except Central and South America), stabilised in 30 countries, and increased in 3 (Romania, Slovenia, and Cuba). Among women, mortality rates decreased in 24 countries, remained stable in 36 countries, and increased in 5 countries (central and eastern Europe).
Conclusions: Incidence and mortality rates in general decreased in most Western countries but increased in some eastern European and developing countries. These patterns in part may reflect differences in the stage and extent of the tobacco epidemic, changes in coding practices, prevalence of schistosomiasis (Africa), and occupational exposure.
Keywords: Epidemiology; Incidence; Mortality; Registries; Schistosoma haematobium; Trends; Urinary bladder cancer.
Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
The global risk of bladder cancer: let's just do something about it!Eur Urol. 2014 Jul;66(1):74-5. doi: 10.1016/j.eururo.2013.11.039. Epub 2013 Dec 2. Eur Urol. 2014. PMID: 24315432 No abstract available.
-
Reply from authors re: Lambertus A. Kiemeney. The global risk of bladder cancer: let's just do something about it! Eur Urol 2014;66:74-5.Eur Urol. 2014 Jul;66(1):76. doi: 10.1016/j.eururo.2013.12.028. Epub 2013 Dec 31. Eur Urol. 2014. PMID: 24411280 No abstract available.
Similar articles
-
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28. Eur Urol. 2017. PMID: 27370177 Review.
-
International variation in prostate cancer incidence and mortality rates.Eur Urol. 2012 Jun;61(6):1079-92. doi: 10.1016/j.eururo.2012.02.054. Epub 2012 Mar 8. Eur Urol. 2012. PMID: 22424666
-
International variations and trends in testicular cancer incidence and mortality.Eur Urol. 2014 Jun;65(6):1095-106. doi: 10.1016/j.eururo.2013.11.004. Epub 2013 Nov 14. Eur Urol. 2014. PMID: 24268506
-
Global trends in testicular cancer incidence and mortality.Eur Urol. 2011 Aug;60(2):374-9. doi: 10.1016/j.eururo.2011.05.004. Epub 2011 May 17. Eur Urol. 2011. PMID: 21612857
-
Worldwide variations in colorectal cancer.CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78. doi: 10.3322/caac.20038. CA Cancer J Clin. 2009. PMID: 19897840 Review.
Cited by
-
Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.Tumour Biol. 2016 Oct;37(10):13385-13390. doi: 10.1007/s13277-016-5177-9. Epub 2016 Jul 27. Tumour Biol. 2016. PMID: 27460088
-
Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.Biomolecules. 2020 Aug 7;10(8):1159. doi: 10.3390/biom10081159. Biomolecules. 2020. PMID: 32784711 Free PMC article. Review.
-
Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study.Medicine (Baltimore). 2019 Sep;98(36):e16873. doi: 10.1097/MD.0000000000016873. Medicine (Baltimore). 2019. PMID: 31490371 Free PMC article.
-
Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy.RSC Adv. 2018 Oct 16;8(62):35395-35402. doi: 10.1039/c8ra06548a. eCollection 2018 Oct 15. RSC Adv. 2018. PMID: 35547901 Free PMC article.
-
Age and risk of major complications in patients undergoing radical cystectomy for muscle invasive bladder cancer.Wideochir Inne Tech Maloinwazyjne. 2021 Dec;16(4):722-727. doi: 10.5114/wiitm.2021.103918. Epub 2021 Feb 24. Wideochir Inne Tech Maloinwazyjne. 2021. PMID: 34950268 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical